MAK Capital One’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

MAK Capital One’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-561,538	Closed	-$139K	–	21
2026 Q1	$139K	Buy	+561,538	New	+$223K	0.02%	22

Other funds holding SGMO

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

AIM

Axiom Investment Management New York $150M AUM

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

MAK Capital One's SGMO Position: Q2 2026 in Review

MAK Capital One sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 561,538 shares — an estimated $139K sold.

MAK Capital One first reported a position in SGMO in Q1 2026 and held it in 1 quarter. The position peaked at $139K in Q1 2026. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

MAK Capital One reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
MAK Capital One sold 561,538 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $139K.
MAK Capital One first reported a position in SANGAMO THERAPEUTICS INC in Q1 2026 and held it in 1 quarter.
MAK Capital One's SANGAMO THERAPEUTICS INC position peaked at $139K in Q1 2026.
6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on MAK Capital One's 13F filing for Q2 2026, filed 14 Aug 2026.